Food and Drug Administration Drug Safety Podcast
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:03:30
- Mais informações
Informações:
Sinopse
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses.
